Osaka, Japan

Kouji Hattori


Average Co-Inventor Count = 4.0

ph-index = 7

Forward Citations = 152(Granted Patents)


Location History:

  • Takarazuka, JP (1998 - 2002)
  • Osaka, JP (2003 - 2009)
  • Chuo-ku, JP (2011)

Company Filing History:


Years Active: 1998-2011

Loading Chart...
15 patents (USPTO):Explore Patents

Title: Kouji Hattori: Innovator in Aminoalcohol Derivatives

Introduction

Kouji Hattori is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of aminoalcohol derivatives. With a total of 15 patents to his name, Hattori's work has had a substantial impact on therapeutic treatments.

Latest Patents

One of Hattori's latest patents involves aminoalcohol derivatives, which relate to a compound of the formula [I]. This invention addresses various compounds where specific groups are defined, including hydrogen, halogen, lower alkyl, and hydroxy. The compound is useful for the prophylactic and therapeutic treatment of conditions such as ulcers and overactive bladder. The detailed structure and potential applications of these compounds highlight Hattori's innovative approach to pharmaceutical development.

Career Highlights

Throughout his career, Kouji Hattori has worked with notable companies in the pharmaceutical industry. He has been associated with Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in drug development.

Collaborations

Hattori has collaborated with esteemed colleagues, including Akira Tanaka and Kiyoshi Taniguchi. These partnerships have fostered a collaborative environment that has led to innovative solutions in the pharmaceutical sector.

Conclusion

Kouji Hattori's contributions to the field of aminoalcohol derivatives exemplify his dedication to innovation in pharmaceuticals. His extensive patent portfolio and collaborative efforts underscore his role as a key figure in advancing therapeutic treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…